Biotech componentsPlant

Products 81 to 90 of 120

Neossance Hemisqualane by Aprinnova
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Japan + Europe
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Finished Product
Neossance Squalane by Aprinnova
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: Australia + Canada + China + Europe + Japan + Korea + Mexico + New Zealand + Philippines + Russia + USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Finished Product
Nootkatone by Isobionics
Biotech components: Plant
Business models: B2B
Country of production: Netherlands
Country of distribution: Netherlands
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Additive
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Orb by BIOHM
Biotech components: Fungus + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/11/19 09:36 (5 years ago)
Date last modified: 2018/11/19 09:36 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: N/A
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Fungus + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/11/19 09:36 (5 years ago)
Date last modified: 2018/11/19 09:36 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Construction + Design
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Plant-Based Pork by Impossible Foods
Biotech components: Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 09:56 (4 years ago)
Date last modified: 2020/02/10 09:56 (4 years ago)
Known funding amount: 687,500,000 USD
Funding types: Private Funding + Venture Capital
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Food
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Pomecin by Evolva
Biotech components: Plant
Business models: B2B
Country of production: Switzerland
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/02 15:44 (5 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Plant
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Input
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/28 14:53 (5 years ago)
Known funding amount: 70,000,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/28 14:35 (5 years ago)
Known funding amount: 70,000,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Salk Ideal Plants by Salk Institute for Biological Studies
Biotech components: Gene Editing + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:08 (5 years ago)
Date last modified: 2019/09/12 15:08 (5 years ago)
Known funding amount: N/A
Funding types: Public Funding
Industry: Ecosystem Restoration + Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Plant
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product